|Articles|February 1, 2014
- BioPharm International-02-01-2014
- Volume 27
- Issue 2
BioPharm International, February 2014 Issue (PDF)
Click the title above to open the BioPharm International February 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Novel Expression Systems Opening CMO Opportunitiesover 11 years ago
EMA Collaborates with HTA Assessment Networksover 11 years ago
Tackling the Challenge of HOS Determinationover 11 years ago
The Affordable Care Act's Impact on Innovation in Biopharmaover 11 years ago
Cytotoxicity Risks in Single-use Media and Bioreactor Containersover 11 years ago
Defining Quality Metrics is No Easy TaskNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
